Among individuals diagnosed with (NAFLD, a higher frequency of lean subjects (30.3%) carried the PNPLA3 rs738409 GG genotype compared to overweight (17.9%) and obese subjects (17.4%). Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.